Coloplast A/S (CLPBF) Research

Coloplast A/S is a global healthcare company specializing in the development and sale of intimate healthcare solutions. Its operations span Denmark, the United States, the United Kingdom, France, and numerous other international markets. The company organizes its business into several key segments: Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care. Within ostomy care, Coloplast offers products such as SenSura Mio, designed to conform to individual body shapes and ensure discretion for various ostomy types. Its SenSura Ostomy care solutions are complemented by Brava brand accessories. For continence management, their portfolio includes Conveen Active urine bags, SpeediCath catheters for both male and female users, and the Peristeen transanal irrigation system. The wound care range features Biatain Silicone conforming dressings and Comfeel hydrocolloid dressings. Skin care offerings encompass a variety of products like cleansers, moisturizers, skin protectants, antifungal treatments, hand sanitizers, and odor control solutions, alongside InterDry for managing skin folds. Coloplast is also involved in the development, production, and commercialization of surgical products addressing various urological and gynecological conditions, including urinary stone disease, benign prostatic hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Furthermore, the company provides voice and respiratory products, specifically medical devices for neck stomas under the Provox brand and tracheostomy products under the TRACOE brand. Established in 1954, Coloplast A/S maintains its headquarters in Humlebæk, Denmark.

Open Coloplast A/S (CLPBF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.